Arrowhead Pharmaceuticals ceo salary

Christopher Anzalone, President and Chief Executive Officer of ARROWHEAD PHARMACEUTICALS, INC. (ARWR), received $9,029,861 ($9.0M) in total compensation for FY2025, down 27.3% from the prior year. Stock awards of $6,810,292 were the largest component. Figures come from ARROWHEAD PHARMACEUTICALS, INC.'s DEF 14A filed 27 Jan 2026 (accession 0000879407-26-000019).

Reported total from the latest DEF 14A pay table. Source filing (accession 0000879407-26-000019). These figures come from ARROWHEAD PHARMACEUTICALS, INC.'s DEF 14A filed 27 Jan 2026 (accession 0000879407-26-000019).

Component	Amount
Salary	$981,046
Stock awards	$6,810,292
Cash incentive	$1,236,000
Other	$2,523
Total	$9,029,861

FAQ

Common questions

How much does the Arrowhead Pharmaceuticals CEO make?: Christopher Anzalone received $9,029,861 in total compensation for FY2025 as President and Chief Executive Officer of ARROWHEAD PHARMACEUTICALS, INC. (ARWR), per ARROWHEAD PHARMACEUTICALS, INC.'s DEF 14A filed 27 Jan 2026 (accession 0000879407-26-000019).
Where does this number come from?: The numbers come from ARROWHEAD PHARMACEUTICALS, INC.'s DEF 14A filed 27 Jan 2026 (accession 0000879407-26-000019).

Arrowhead Pharmaceuticals ceo salary

Christopher Anzalone, President and Chief Executive Officer of ARROWHEAD PHARMACEUTICALS, INC. (ARWR), received $9,029,861 ($9.0M) in total compensation for FY2025, down 27.3% from the prior year. Stock awards of $6,810,292 were the largest component. Figures come from ARROWHEAD PHARMACEUTICALS, INC.'s DEF 14A filed 27 Jan 2026 (accession 0000879407-26-000019).

Reported total from the latest DEF 14A pay table. Source filing (accession 0000879407-26-000019). These figures come from ARROWHEAD PHARMACEUTICALS, INC.'s DEF 14A filed 27 Jan 2026 (accession 0000879407-26-000019).

Component	Amount
Salary	$981,046
Stock awards	$6,810,292
Cash incentive	$1,236,000
Other	$2,523
Total	$9,029,861

FAQ

Common questions

How much does the Arrowhead Pharmaceuticals CEO make?: Christopher Anzalone received $9,029,861 in total compensation for FY2025 as President and Chief Executive Officer of ARROWHEAD PHARMACEUTICALS, INC. (ARWR), per ARROWHEAD PHARMACEUTICALS, INC.'s DEF 14A filed 27 Jan 2026 (accession 0000879407-26-000019).
Where does this number come from?: The numbers come from ARROWHEAD PHARMACEUTICALS, INC.'s DEF 14A filed 27 Jan 2026 (accession 0000879407-26-000019).